The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The US Food and Drug Administration (FDA) announced its approval of a non-opioid treatment for moderate–severe acute chronic ...

Your feet can tell you a lot about your general health condition or warn you of underlying health conditions. From pesky foot ...

Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

If you would like to learn how Regenerative Neuropathy can reverse your neuropathy symptoms without prescriptions or addictive medications, call 618-206-5924. Regenerative Neuropathy of O’Fallon ...

TUESDAY, Jan. 14, 2025 (HealthDay News) -- Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, ...

Type 1 and 2 diabetes are common conditions, but other types of diabetes are less known. Despite different causes, the results are the same: your body cannot produce enough or properly use insulin to ...

Our team looked at over 100 of the top auto insurance providers in the U.S., from national providers like USAA, Travelers and State Farm to regional providers like Erie Insurance. 8,500 Data ...

Lean diabetes (defined as those with a BMI level of under 25 and random blood glucose levels of over 200 requiring diabetic medication) may lead to more complications than diabetes among the obese, ...

Diabetic neuropathy is the most common neuropathy in industrialized countries, and it is associated with a wide range of clinical manifestations. The vast majority of patients with clinical ...